Esketamine for Treatment-Resistant Depression

Authors

Institutions

Publication Details

Journal
JAMA Psychiatry
Published
2025-11-05
DOI
https://doi.org/10.1001/jamapsychiatry.2025.3242
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Esketamine for Treatment-Resistant Depression

Martin Plöderl, Ioana A. Cristea, Florian Naudet
JAMA Psychiatry
Treatment of Major Depression
article

Esketamine for Treatment-Resistant Depression

Martin Plöderl, Ioana A. Cristea, Florian Naudet
article en

Abstract

No abstract available for this paper.
JAMA PsychiatryVol. 83(1)
University of Padua (IT), Inserm (FR), Paracelsus Medical University (AT), Institut de Recherche en Santé, Environnement et Travail (FR)
Openalex Percentile: Top 63%
Treatment of Major Depression
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Esketamine for Treatment-Resistant Depression — Martin Plöderl, Ioana A. Cristea, et al. · JAMA Psychiatry (2025) | TGRS Research Map | TGRS